Sun Pharma's Leukaemia Drug Receives Tentative Approval From FDA

http://regulatoryaffairs.pharmaceutical-business-review.com/news/sun_pha...

Drug, therapeutically equal to Gleevec tablets from Novartis

Sun Pharma announced that the FDA has granted tentative approval to an Abbreviated New Drug Application (ANDA) for generic Gleevec, imatinib mesylate tablets.